// App-Quantinova.ai

: Prevalence of ARV7 in Asian metastatic castrate-resistant prostate cancer (mCRPC) patients using multiple detection platforms.

Researchers

Presenter

  • Johan Chan

Principal Investigators

  • Whee Sze Ong

  • Quan Sing Ng

  • Chee-Keong Toh

  • Tanujaa Rajasekaran

  • Wan Ling Tan

  • Hui Shan Tan

  • Min-Han Tan

  • Kiat Hon Lim

  • Yifang Lee

  • Siew Wei Wong

  • Alvin SC Wong

  • Marniza Bte Saad

  • Chi-Fai Ng

  • Phichai Chansriwong

  • Shigeo Horie

  • Ravindran Kanesvaran

Medical Centers

  • National Cancer Centre Singapore, Singapore, Singapore

  • Department of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore

  • Singapore General Hospital, Singapore, Singapore

  • Clearbridge Biomedics Pte Ltd, Singapore, Singapore

  • Tan Tock Seng Hospital, Singapore, SC, Singapore

  • Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore, Singapore

  • University Malaya Medical Center, Kuala Lumpur, Malaysia

  • University of Hong Kong, Hong Kong, China

  • Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

Locations

  • Singapore

  • Malaysia

  • China

  • Thailand

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Androgen receptor variant 7

  • Circulating tumor cells

  • Prostate specific antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved